Skip to main content
. 2024 Feb 25;16(5):932. doi: 10.3390/cancers16050932

Figure 3.

Figure 3

Therapeutic algorithms. Legend: 1L first line; PSROC potentially platinum sensitive recurrent ovarian cancer; PRO potentially platinum resistant ovarian cancer; sMx switch maintenance; mut mutation.